---
figid: PMC3177043__13539_2011_35_Fig2_HTML
figtitle: Different pathways of myostatin signalling
organisms:
- NA
pmcid: PMC3177043
filename: 13539_2011_35_Fig2_HTML.jpg
figlink: /pmc/articles/PMC3177043/figure/Fig2/
number: F2
caption: 'Different pathways of myostatin signalling. → The activation of the process,
  -| the inhibition of the process, -- -- the presence of intermediate steps either
  unknown or omitted in the figure. 1 Canonical pathway of Smad activation. Myostatin
  binds to ActRIIB and induces its assembly with activin type I receptor. Subsequent
  phosphorylation of Smad2/3 leads to its binding with Smad4 and translocation of
  the complex to the nucleus where it blocks the transcription of genes responsible
  for the myogenesis. Smad6 and Smad7 compete for the binding with activin type I
  receptor. Smad7 can also prevent the formation of the Smad 2/3 and Smad4 complex.
  2 MAPK activation. The activation of MAPKs is mediated via myostatin using different
  pathways: TAK-1/MAPKK for p38 MAPK or Ras/Raf/MEK1 for ERK1/2. It leads to the blockade
  of genes responsible for myogenesis. 3 Inhibition of Akt signalling. Akt phosphorylation
  occurs in the response to insulin and IGF-1. In normal case, active Akt induces
  mTOR signal leading to the protein synthesis; at the same time, it inhibits FoxO
  by phosphorylation. In the pathological conditions, dephosphorylated Akt does not
  inhibit FoxO. It leads to the accumulation of FoxO in the nucleus where it binds
  to the DNA and induces the transcription of E3 ubiquitin ligases MURF-1 and Atrogin-1.
  Smad3 and Smad4 possibly participate in FoxO signalling (adapted from [, , , ])'
papertitle: 'The role of myostatin in muscle wasting: an overview.'
reftext: Yulia Elkina, et al. J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):143-151.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.962985
figid_alias: PMC3177043__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3177043__F2
ndex: 85ba3fe0-ded4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3177043__13539_2011_35_Fig2_HTML.html
  '@type': Dataset
  description: 'Different pathways of myostatin signalling. → The activation of the
    process, -| the inhibition of the process, -- -- the presence of intermediate
    steps either unknown or omitted in the figure. 1 Canonical pathway of Smad activation.
    Myostatin binds to ActRIIB and induces its assembly with activin type I receptor.
    Subsequent phosphorylation of Smad2/3 leads to its binding with Smad4 and translocation
    of the complex to the nucleus where it blocks the transcription of genes responsible
    for the myogenesis. Smad6 and Smad7 compete for the binding with activin type
    I receptor. Smad7 can also prevent the formation of the Smad 2/3 and Smad4 complex.
    2 MAPK activation. The activation of MAPKs is mediated via myostatin using different
    pathways: TAK-1/MAPKK for p38 MAPK or Ras/Raf/MEK1 for ERK1/2. It leads to the
    blockade of genes responsible for myogenesis. 3 Inhibition of Akt signalling.
    Akt phosphorylation occurs in the response to insulin and IGF-1. In normal case,
    active Akt induces mTOR signal leading to the protein synthesis; at the same time,
    it inhibits FoxO by phosphorylation. In the pathological conditions, dephosphorylated
    Akt does not inhibit FoxO. It leads to the accumulation of FoxO in the nucleus
    where it binds to the DNA and induces the transcription of E3 ubiquitin ligases
    MURF-1 and Atrogin-1. Smad3 and Smad4 possibly participate in FoxO signalling
    (adapted from [, , , ])'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FSTL3
  - GPRASP1
  - WFIKKN2
  - LTBP3
  - IGF1
  - INHBA
  - INHBB
  - IGF1R
  - SMAD6
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP3K7
  - NR2C2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAP2K1
  - MTOR
  - GSK3B
  - RPTOR
  - MAPKAP1
  - RICTOR
  - MLST8
  - TRIM63
  - RPS6KB1
  - RPS6KB2
  - CCND1
  - Cancer
  - Lung cancer
  - Noonan syndrome
---
